J Fluoresc
phthalocyanines: effects of the carbon chain length. Polyhedron
88:73–80
13. Sholto A, Ehrenberg B (2008) Hydrophobicity, topography in
membranes and photosensitization of siliconphthalocyanines
with axial ligands of varying lengths. Photochem Photobiol
Sci 7:344–351
14. Lo PC, Leung SCH, Chan EYM, Fong WP, Ko WH, Ng DKP
(2007) Photodynamic effects of a novel series of silicon(IV) phtha-
locyanines against human colon adenocarcinoma cells. Photodiagn
Photodyn Ther 4:117–123
15. Priscilla PSL, Pui-Chi L, Elaine YMC, Ng KPD (2005) Synthesis
and in vitro photodynamic activity of novel galactose-containing
phthalocyanines. Tetrahedron Lett 46:1551–1554
16. Lau JTF, Lo PC, Tsang YM, Fong WP, Ng DKP (2011)
Unsymmetrical β-cyclodextrin-conjugated silicon(IV) phthalocya-
nines as highly potent photosensitisers for photodynamic therapy.
Chem Commun 47:9657–9659
17. Mao J, Zhang Y, Zhu J, Zhang C, Guo Z (2009) Molecular combo
of photodynamic therapeutic agent silicon(IV) phthalocyanine and
anticancer drug cisplatin. Chem Commun:908–910
18. Zhu YJ, Huang JD, Jiang XJ (2006) Novel silicon phthalocyanines
axially modified by morpholine: synthesis, complexation with se-
rum protein and in vitro photodynamic activity. Inorg Chem
Commun 9:473–477
is required. Their stabilities were also checked in different
solvents and some spectral changes for axially substituted
compound 1 and 2 with ester bond were obtained in DMF.
The spectral changes and analysis showed that ester bond
hydrolysis took place in DMF. Interestingly, singlet oxygen
quantum yields of the products obtained the result of decom-
position were higher than the stable form. We concluded that
these molecules are good candidates as combined chemother-
apy agent and photosensitizer for cancer treatment. Because
cancers cells are more acidic than normal cells, the sulindac
group could be cleaved when these compounds reach the can-
cer cells. As a result, the hydrolysed SiPc complexes could
serve as photosensitizer with higher singlet oxygen yield and
sulindac serve as chemotherapy agent for cancer treatment.
Acknowledgements The Scientific and Technological Research
Council of Turkey (TUBITAK) is gratefully acknowledged (project
114Z463 coupled to the COST Action CM1106).
19. Hofman JW, Zeeland F, Turker S, Talsma H, Lambrechts SAG,
Sakharov DV, Hennick WE, Nostrum CF (2007) Peripheral and
axial substitution of phthalocyanines with solketal groups: synthe-
sis and in vitro evaluation for photodynamic therapy. J Med Chem
50:1485–1494
20. Li H, Jensen TJ, Fronczek FR, Vicente GH (2008) Syntheses and
properties of a series of cationic water-soluble phthalocyanines. J
Med Chem 51:502–511
21. Anula HM, Berlin JC, Wu H, Li YS, Peng X, Kenney ME, Rodgers
MAJ (2006) Synthesis and photophysical properties of silicon
phthalocyanines with axial siloxy ligands bearing alkylamine ter-
mini. J Phys Chem A 110:5215–5223
22. Cordoba WR, Noria R, Guarin CA, Peon J (2011) Ultrafast photo-
sensitization of phthalocyanines through their axial ligands. J Am
Chem Soc 133:4698–4701
References
1. Detty MR, Gibson SL, Wagner SJ (2004) Current clinical and pre-
clinical photosensitizers for use in photodynamic therapy. J Med
Chem 47(16):3897–3915
2. Plaetzer K, Krammer B, Berlanda J, Berr F, Kiesslich T (2009)
Photophysics and photochemistry of photodynamic therapy: funda-
mental aspects. Lasers Med Sci 24:259–268
3. Robertson CA, Evans DH, Abrahamse H (2009) Photodynamic
therapy (PDT): a short review on cellular mechanisms and cancer
research applications for PDT. J Photochem Photobiol B 96(1):1–8
4. Allison RR, Sibata CH (2010) Oncologic photodynamic therapy
photosensitizers: a clinical review. Photodiagn Photodyn Ther 7:
61–75
23. Baron ED, Malbasa CL, Santa Domingo D, Fu P, Miller JD,
Hanneman KK, Hsia AH, Oleinick NL, Colussi VC, Cooper KD
(2010) Silicon phthalocyanine (pc 4) photodynamic therapy is a
safe modality for cutaneous neoplasms: results of a phase 1 clinical
trial. Laser Surg Med 42:728–735
24. Foster TH, Giesselman BR, Hu R, Kenney ME, Mitra S (2007)
Intratumor administration of the photosensitizer pc 4 affords pho-
todynamic therapy efficacy and selectivity at short drug-light inter-
vals. Toxicol Appl Pharm 224:290–299
25. Oleinick NL, Antunez AR, Clay ME, Rihter BD, Kenney ME
(1993) New phthalocyanine photosensitizers for photodynamic
therapy. J Photochem Photobiol 57:242–247
26. Conte C, Ungaro F, Maglio G, Tirino P, Siracusano G, Sciortino
MT, Leone N, Palma G, Barbieri A, Arra C, Mazzaglia A, Quaglia
F (2013) Biodegradable core-shell nanoassemblies for the delivery
of docetaxel and Zn(II)-phthalocyanine inspired by combination
therapy for cancer. J Control Release 167:40–52
27. Ma D, Liu Z, Zheng Q, Zhou X, Zhang Y, Shi Y, Lin J, Xue W
(2013) Star-shaped polymer consisting of a porphyrin core and
poly(L-lysine) dendron arms: synthesis, drug delivery, and
in vitro chemo/photodynamic therapy. Macromol Rapid
Commun 34:548–552
28. Kakiuchi Y, Tsuji S, Tsujii M, Murata H, Kawai N, Yasumaru M,
Kimura A, Komori M, Irie T, Miyoshi E, Sasaki Y, Hayashi N,
Kawano S, Hori M (2002) Cyclooxygenase-2 activity altered the
cell-surface carbohydrate antigens on colon cancer cells and en-
hanced liver metastasis. Cancer Res 62(5):1567–1572
5. Asem H, El-Fettah A, Nafee N, Zhao Y, Khalil L, Mamoun M,
Moustapha H, Kandil S (2016) Development and biodistribution
of a theranostic aluminum phthalocyanine nanophotosensitizer.
Photodiagn Photodyn Ther 13:48–57
6. Dumoulin F, Durmuş M, Ahsen V, Nyokong T (2010) Synthetic
pathways to water-soluble phthalocyanines and close analogs.
Coord Chem Rev 254:2792–2847
7. Tabata K, Fukushima K, Oda K, Okura I (2006) Selective aggrega-
tion of zinc phthalocyanines in the skin. J Porphyrins
Phthalocyanines 10:1116–1124
8. Allen CM, Sharman WM, Van Lier JE (2001) Current status of
phthalocyanines in the photodynamic therapy of cancer. J
Porphyrins Phthalocyanines 5:161–169
9. Jiang XJ, Huang JD, Zhu YJ, Tang FX, Ng KPD (2006) Preparation
and in vitro photodynamic activities of novel axially substituted
silicon (IV) phthalocyanines and their bovine serum albumin con-
jugates. Bioorg Med Chem Letters 16:2450–2453
10. Evren D, Özçeşmeci İ, Sesalan BŞ, Burat KA (2013) Investigation
of the biological properties of water soluble quinoline substituted
phthalocyanines. Synth Met 168:31–35
11. Lochman L, Svec J, Roh J, Novakova V (2015) The role of the size
of aza-crown recognition moiety in azaphthalocyanine fluorescence
sensors for alkali and alkaline earth metal cations. Dyes Pigments
121:178–187
12. Bankole MO, Britton J, Nyokong T (2015) Photophysical and non-
linear optical behavior of novel tetra alkynyl terminated indium